[1]
|
Song, P., Xu, Y., Zha, M., Zhang, Y. and Rudan, I. (2019) Global Epidemiology of Retinal Vein Occlusion: A System-atic Review and Meta-Analysis of Prevalence, Incidence, and Risk Factors. Journal of Global Health, 9, Article ID: 010427. https://doi.org/10.7189/jogh.09.010427
|
[2]
|
Holló, G., Aung, T., Cantor, L.B. and Aihara, M. (2020) Cystoid Macular Edema Related to Cataract Surgery and Topical Prostaglandin Analogs: Mechanism, Diagnosis, and Management. Survey of Ophthalmology, 65, 496-512.
https://doi.org/10.1016/j.survophthal.2020.02.004
|
[3]
|
Nicholson, L., Talks, S.J., Amoaku, W., Talks, K. and Si-vaprasad, S. (2022) Retinal Vein Occlusion (RVO) Guideline: Executive Summary. Eye, 36, 909-912. https://doi.org/10.1038/s41433-022-02007-4
|
[4]
|
Ji, K., Zhang, Q., Tian, M. and Xing, Y. (2019) Comparison of Dexamethasone Intravitreal Implant with Intravitreal Anti-VEGF Injections for the Treatment of Macular Edema Second-ary to Branch Retinal Vein Occlusion: A Meta-Analysis. Medicine, 98, e15798. https://doi.org/10.1097/MD.0000000000015798
|
[5]
|
Lapp, T., Wacker, K., Heinz, C., Maier, P., Eberwein, P. and Reinhard, T. (2023) Cataract Surgery-Indications, Techniques, and Intraocular Lens Selection. DÄ International: Deutsches Ärzteblatt, 120, 377-386.
https://doi.org/10.3238/arztebl.m2023.0028
|
[6]
|
Chu, C.J., Johnston, R.L., Buscombe, C., Sallam, A.B., Mohamed, Q. and Yang, Y.C. and United Kingdom Pseudophakic Macular Edema Study Group (2016) Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. Ophthalmology, 123, 316-323. https://doi.org/10.1016/j.ophtha.2015.10.001
|
[7]
|
Cho, H.J., Hwang, H.J., Kim, H.S., Lee, D.W., Kim, C.G., Kim, B.Y. and Kim, J.W. (2018) Macular Edema after Cataract Surgery in Eyes with Preoperative Retinal Vein Occlusion. Retina, 38, 1180-1186.
https://doi.org/10.1097/IAE.0000000000001668
|
[8]
|
Sawada, O. and Ohji, M. (2016) Retinal Vein Occlusion. Developments in Ophthalmology, 55, 147-153.
https://doi.org/10.1159/000438971
|
[9]
|
Wielders, L.H.P., Schouten, J.S.A.G. and Nuijts, R.M.M.A. (2018) Pre-vention of Macular Edema Aftercataract Surgery. Current Opinion in Ophthalmology, 29, 48-53. https://doi.org/10.1097/ICU.0000000000000436
|
[10]
|
Massa, H., Georgoudis, P. and Panos, G.D. (2019) Dexa-methasone Intravitreal Implant (OZURDEX®) for Macular Edema Secondary to Noninfectious Uveitis: A Review of the Literature. Therapeutic Delivery, 10, 343-351.
https://doi.org/10.4155/tde-2019-0024
|
[11]
|
Wang, J.K. (2016) A Review of Randomized Trials of Approved Pharmaceutical Agents for Macular Edema Secondary to Retinal Vein Occlusion. The Asia-Pacific Journal of Ophthal-mology, 5, 159-164.
https://doi.org/10.1097/APO.0000000000000168
|
[12]
|
Modi, Y.S., Klufas, M.A., Sridhar, J., Singh, R.P., Yonekawa, Y. and Pecen, P. (2020) Current Best Clinical Practices-Management of Retinal Vein Occlusion. Journal of VitreoRetinal Diseases, 4, 214-219.
https://doi.org/10.1177/2474126420906395
|
[13]
|
Clark, W.L., Boyer, D.S., Heier, J.S., Brown, D.M., Haller, J.A., Vitti, R., Kazmi, H., Berliner, A.J., Erickson, K., Chu, K.W., Soo, Y., Cheng, Y. and Campochiaro, P.A. (2016) Intravi-treal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study. Ophthalmology, 123, 330-336.
https://doi.org/10.1016/j.ophtha.2015.09.035
|
[14]
|
Valašková, J., Popov, I. and Krásnik, V. (2018) Combination of Intravitreal Corticosteroid with Anti-Vegf in Macular Edema Secondary to Retinal Vein Occlusion. Czech and Slovak Ophthalmology, 73, 183-188.
|
[15]
|
Kim, J.H., Shin, J.P., Kim, I.T. and Park, D.H. (2016) Aqueous Angiopoietin-Like 4 Levels Correlate with Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion. Investigative Ophthal-mology & Visual Science, 57, 6-11.
|
[16]
|
Garweg, J.G. and Zandi, S. (2016) Retinal Vein Occlusion and the Use of a Dexamethasoneintravitreal Implant (Ozurdex®) in Its Treatment. Graefe’s Archive for Clinical and Experimental Oph-thalmology, 254, 1257-1265.
https://doi.org/10.1007/s00417-016-3350-x
|
[17]
|
Iftikhar, M., Dun, C., Schein, O.D., Lum, F. and Woreta, F. (2023) Cystoid Macular Edema after Cataract Surgery in the United States: IRIS® Registry (Intelligent Research InSight) Anal-ysis. Ophthalmology, 130, 1005-1014.
https://doi.org/10.1016/j.ophtha.2023.06.001
|
[18]
|
Nishida, A., Kojima, H., Kameda, T., Mandai, M. and Kurimoto, Y. (2017) Five-Year Outcomes of Pars Plana Vitrectomy for Macular Edema Associated with Branch Retinal Vein Oc-clusion. Clinical Ophthalmology, 11, 369-375.
https://doi.org/10.2147/OPTH.S123419
|
[19]
|
Campochiaro, P.A., Clark, W.L., Boyer, D.S., Heier, J.S., Brown, D.M., Vitti, R., Kazmi, H., Berliner, A.J., Erickson, K., Chu, K.W., Soo, Y., Cheng, Y. and Haller, J.A. (2015) Intravi-trealaflibercept for Macular Edema Following Branch Retinal Vein Occlusion: The 24-Week Results of the VIBRANT Study. Ophthalmology, 122, 538-544.
https://doi.org/10.1016/j.ophtha.2014.08.031
|
[20]
|
Chen, G., Chen, P., Chen, X., Wang, J. and Peng, X. (2021) The Laser Combined with Intravitrealinjection of Ranibizumab for Treatment of Macular Edema Secondary to Branchretinal Vein Occlusion: A Protocol for Systematic Review and Meta-Analysis. Medicine, 100, e23675. https://doi.org/10.1097/MD.0000000000023675
|
[21]
|
Ponder, C.M., Rather, P.A., Soliman, M.K., Jabbehdari, S., Neuhouser, A., Siddiqui, M.Z., Yang, Y.C. and Sallam, A.B. (2022) Intraoperative Complications and Visual Outcomes of Cataractsurgery in Patients with Retinal Vein Occlusion: Multicenter Database Study. Journal of Cataract & Refractive Surgery, 48, 697-704.
https://doi.org/10.1097/j.jcrs.0000000000000829
|
[22]
|
Proença Pina, J., Turki, K., Labreuche, J., Duhamel, A. and Tran, T.H. (2016) Efficacy and Safety in Retinal Vein Occlusion Treated with at Least Three Consecutive Intravitreal Dexamethasone Implants. Journal of Ophthalmology, 2016, Article ID: 6016491. https://doi.org/10.1155/2016/6016491
|
[23]
|
Li, X.D. and Xie, X.J. (2022) The Efficacy and Safety of Dexame-thasone IntravitrealImplant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials. Journal of Ophthalmology, 2022, Article ID: 4007002. https://doi.org/10.1155/2022/4007002
|
[24]
|
Wei, Q., Sun, T., Wan, Z., Zhang, Y. and Peng, Q. (2020) Cytokine and Chemokine Profile Changesin Patients after Intravitreal Conbercept Injection for Center Macular Edema Dueto Branch Retinal Vein Occlusion. American Journal of Translational Research, 12, 4001-4008.
|
[25]
|
Starr, M.R., Mahr, M.A., Iezzi, R., Barkmeier, A.J. and Bakri, S.J. (2020) Visual and Anatomic Outcomes Following Cataract Surgery in Patients with Pre-Operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal Anti-VEGF. Seminars in Ophthalmology, 35, 205-209. https://doi.org/10.1080/08820538.2020.1772319
|
[26]
|
Nicula, C., Nicula, D., Rednik, A., Bulboaca, A. and Crișan, O. (2020) Morphological and Functional Outcomes after Intravitreal Dexame-thasone Injection for Macular Edemain Patients with Central Vein Occlusion at 48-Week Follow-Up. Journal of Oph-thalmology, 2020, Article ID: 6830148. https://doi.org/10.1155/2020/6830148
|
[27]
|
Blanc, J., Deschasse, C., Ko-djikian, L., Dot, C., Bron, A.M. and Creuzot-Garcher, C. (2018) Safetyand Long-Term Efficacy of Repeated Dexame-thasone Intravitreal Implants for Thetreatment of Cystoid Macular Edema Secondary to Retinal Vein Occlusion with or without a Switch to Anti-VEGF Agents: A 3-Year Experience. Graefe’s Archive for Clinical and Experimental Oph-thalmology, 256, 1441-1448. https://doi.org/10.1007/s00417-018-4016-7
|
[28]
|
Huang, Y., Linghu, M., Hu, W. and Huang, X. (2022) Conbercept Improves Macularmicrocirculation and Retinal Blood Supply in The Treatment of Nonis-chemic Branchretinal Vein Occlusion Macular Edema. Journal of Clinical Laboratory Analysis, 36, e24774. https://doi.org/10.1002/jcla.24774
|
[29]
|
Lai, C.C. and Kuo, S.C. (2023) Real-World Experience on Intravitreal Dexamethasone Implantin Patients with Macular Edema Scheduled to Undergo Cataract Surgery. BMC Ophthalmology, 23, Article No. 352.
https://doi.org/10.1186/s12886-023-03093-y
|
[30]
|
Soliman, M.K., Zarranz-Ventura, J., Chakravarthy, U., McKib-bin, M., Brand, C., Menon, G., Cilliers, H., Natha, S., Ross, A., Sarhan, M., Lobo, A., Chong, V., Mahmood, S., Islam, N., Akerele, T., Shakarchi, A. and Sallam, A. and United Kingdom Ozurdex in Retinal Vein Occlusion Electronic Medi-cal Records (UK Ozurdex RVO EMR) Users Group (2023) Unitedkingdom Database Study of Intravitreal Dexame-thasone Implant (Ozurdex) Formacular Edema Related to Retinal Vein Occlusion. Retina, 43, 679-687. https://doi.org/10.1097/IAE.0000000000003698
|
[31]
|
Shalchi, Z., Mahroo, O., Bunce, C. and Mitry, D. (2020) Anti-Vascular Endothelial Growth Factor for Macular Oedema Secondary to Branch Retinal Vein Occlusion. Cochrane Database of Systematic Reviews, 7, CD009510.
https://doi.org/10.1002/14651858.CD009510.pub3
|
[32]
|
Yong, H., Qi, H., Yan, H., Wu, Q. and Zuo, L. (2021) The Correlation between Cytokine Levels in the Aqueous Humor and the Prognostic Value of Anti-Vascular Endothelial Growth Factor Therapy for Treating Macular Edema Resulting from Retinal Vein Occlusion. Graefe’s Archive for Clini-cal and Experimental Ophthalmology, 259, 3243-3250.
https://doi.org/10.1007/s00417-021-05211-2
|
[33]
|
Tservakis, I., Koutsandrea, C., Papaconstantinou, D., Par-askevopoulos, T. and Georgalas, I. (2015) Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for Thetreatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion Ineyes Previously Treated with An-ti-Vascular Endothelial Growth Factors. Current Drug Safety, 10, 145-151. https://doi.org/10.2174/1574886309666140805142245
|
[34]
|
Bayat, A.H., Bölükbasi, S., Erden, B., Cakir, A., Ozturan, S.G., Tayfur, M. and Elcioglu, M.N. (2019) A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone ForMacular Edema Secondary to Branch Retinal Vein Occlusion. Beyoglu Eye Journal, 4, 131-135. https://doi.org/10.14744/bej.2019.18291
|
[35]
|
Mishra, S.K., Gupta, A., Patyal, S., Kumar, S., Raji, K., Singh, A. and Sharma, V. (2018) Intravitreal Dexamethasone Implant versus Triamcinolone Acetonide for Macularoedema of Cen-tral Retinal Vein Occlusion: Quantifying Efficacy and Safety. International Journal of Retina and Vitreous, 4, Article No. 13. https://doi.org/10.1186/s40942-018-0114-2
|
[36]
|
Houben, I., De Zaeytijd, J., Deghislage, C., Frost, N.A., Nijs, I. and Van Calster, J. (2018) Efficacy of Multiple Dexamethasone Intravitreal Implants for Refractory Retinal Vein Oc-clusion-Related Macular Edema and Effect of Prior Vitrectomy. Journal of Ocular Pharmacology and Therapeutics, 34, 710-719. https://doi.org/10.1089/jop.2018.0012
|
[37]
|
Hwang, D.K., Chang, Y.L., Lin, T.C., Peng, C.H., Chien, K.H., Tsai, C.Y., Chen, S.J., Chen, K.H. and Hsu, M.Y. (2020) Changes in the Systemic Expression of Sirtuin-1 and Oxidative Stress after Intravitreal Anti-Vascular Endothelial Growth Factor in Patients with Retinal Vein Occlusion. Bi-omolecules, 10, Article 1414.
|
[38]
|
Yucel, O.E., Birinci, H. and Sullu, Y. (2019) The Short-Term Efficacy of Intravitreal Ranibizumab, Aflibercept and Dexamethasone Implant in the Treatment of Macularedema Due to Non-Ischemic Central Retinal Vein Occlusion. International Ophthalmology, 39, 891-901. https://doi.org/10.1007/s10792-018-0890-6
|
[39]
|
Yoon, Y.H., Kim, J.W., Lee, J.Y., Kim, I.T., Kang, S.W., Yu, H.G., Koh, H.J., Kim, S.S., Chang, D.J. and Simonyi, S. (2018) Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study. Oph-thalmologica, 240, 81-89.
https://doi.org/10.1159/000487547
|